The Institute of Human Biology (IHB) enables scientists to pioneer human model systems, accelerating the development of new medicines to improve the lives of patients
ModulaSENSE Bitter can be applied across a wide range of oral dosage forms – including solid, liquid, and semi-solid formulations
Hear how the Program of Glyco-Immunology and Oncology (PGIO) is deciphering cancer’s ‘glyco code’ to pave the way for more precise diagnostics and next generation immunotherapies.
A web-based tool designed to simplify instrument configuration and accelerate the quote request process
See how Life Science Group and Absolute Antibody partner to deliver a flexible antibody offering for future-focused life sciences research
Neurological disorder research is evolving from single cells to complex networks thanks to 3D brain cultures and multielectrode arrays
First-of-its-kind assay by Vector Laboratories and Spatomics enables simultaneous mapping of proteins and glycans on a single slide
Dale brings more than 30 years’ experience across the life sciences sector, with a background spanning bioprocessing, company building, and board leadership
StatLab and Thermo Fisher Scientific among those recognized
Twelve emerging life science startups to showcase enabling technologies at the SLAS European Conference and Exhibition in Vienna, May 19-21
By offering shared access to instrumentation and experienced cryo-EM scientists, the center allows companies to evaluate and incorporate the technology into existing workflows without building the infrastructure in-house
Michael Richardson explains how Inotiv is unlocking new insights into disease mechanisms and therapeutic effectiveness using spatial transcriptomics, proteomics, and AI-powered image analytics.
In an era where algorithmic hypothesis generation outpaces experimental validation capacity, the Centre of Excellence positions Arctoris at the critical interface between computational design and empirical truth
Three therapeutic targets selected across high‑value clinical indications pipeline planned for four radiotherapy assets with in vivo data expected by end of 2026
Programme to focus on advancement of animal-replacement technologies and transition towards human-first, AI-driven drug discovery
This guest editorial explores how emerging AI tools are significantly enhancing the utility of flow cytometry across life sciences and highlights how industry leaders must work together to overcome challenges
Scientists at the University of Edinburgh engineered E. coli bacteria to turn a type of plastic used widely in food and drink packaging – polyethylene terephthalate, or PET – into L-DOPA
Phesi founder, Dr. Gen Li, shares how patient-centric data science and AI are set to transform global healthcare outcomes in cancer
Cast your vote today for the chance to win a $100 Amazon Gift Card
Leadership team is strengthened to support next phase of growth as organization evolves to meet needs of global drug discovery community
Cutting-edge technologies and collaborative research are transforming how scientists overcome genomic instability and accelerate therapeutic protein production
Jiahui International Cancer Center (JICC) stabilized non‑small cell lung cancer (NSCLC) and Parkinson's disease in patient using novel immunotherapy ivonescimab
By adopting Simplicis Ledger™, Flare Therapeutics replaces manual 'human-babysitting' of data with automation-ready infrastructure to scale life sciences R&D
ExPERT DTx streamlines workflows by processing up to 96 samples in a single, three-minute run
Industry leaders outlined how artificial intelligence, digital lab orchestration, and scalable automation will transform scientific discovery and operational resilience in 2026 and beyond
